US Patent 7342006 Substituted 8-heteroaryl xanthines
Patent 7342006 was granted and assigned to ADENOSINE THERAPEUTICS, LLC on March, 2008 by the United States Patent and Trademark Office.
All edits
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Guoquan Wang0
Jayson M. Rieger0
Robert D. Thompson0
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+100 characters)
Article
Patent abstract
Selective antagonists of A2B adenosine receptors like those of formula I are provide.
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07342006 Substituted 8-heteroaryl xanthines US Patent 7342006 Substituted 8-heteroaryl xanthines
Infobox
Patent Number
073420060
Patent Number
73420060
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
073420060
Date of Patent
March 11, 2008
0Patent Application Number
109235920
Date Filed
August 20, 2004
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 23 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07342006 Substituted 8-heteroaryl xanthines
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07342006
Date of patent
March 11, 2008
Patent application number
10923592
Date Filed
August 20, 2004
Patent primary examiner
Find more entities like US Patent 7342006 Substituted 8-heteroaryl xanthines
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.